№ lp_2_3_52627
File format: docx
Character count: 4294
File size: 190 KB
Year:
2024
Region / city:
United Kingdom
Topic:
Health, Medical Condition
Document Type:
Patient Information Leaflet
Organization / Institution:
BritSPAG Executive Committee
Author:
BritSPAG Executive Committee
Target Audience:
Teenagers, young adults, individuals with PCOS or at risk
Period of validity:
Ongoing
Approval Date:
January 2024
Date of amendments:
Not specified
Contextual description:
Information leaflet explaining polycystic ovary syndrome (PCOS) in teenagers and young adults, with details on symptoms, diagnosis, treatment options, and resources for support.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Study Population:
PCOS patients and control groups
Sample Size:
33,638–412,022 depending on subgroup
Variables:
Obesity, Age, Smoking History, Alcohol Consumption, Mental Disorders
Mental Disorders:
Schizophrenia, Depressive Disorder, Bipolar Disorder, Anxiety Disorder, Sleep Disorder
Analysis Type:
Hazard Ratios, Adjusted and Unadjusted
Adjustment Factors:
Age, Diabetes Mellitus, Hypertension, Dyslipidemia, Body Mass Index, Smoking, Alcohol Intake
Data Source:
Clinical and epidemiological study dataset
Document Type:
Supplementary Material
Target Audience:
Researchers and clinicians in endocrinology and psychiatry
Period Covered:
Not explicitly stated, cross-sectional and longitudinal comparisons
Year:
2026
Region / Country:
United Kingdom
Topic:
Health / Reproductive Health
Document Type:
Informational Article
Institution:
IVI Fertility Clinic
Author:
Dr Israel Ortega
Target Audience:
Women experiencing or at risk of PCOS
Health Concerns Covered:
Infertility, Diabetes, Heart Disease, Hormonal Imbalance
Symptoms Discussed:
Irregular periods, weight gain, acne, hair loss, excessive hair growth
Diagnosis Methods:
GP consultation, ultrasound, blood tests
Treatment Options:
Weight management, contraceptive pill, fertility medication (Clomifene)
Publication Date:
2026
Contact Information:
[email protected] / 020 7025 1363
Context:
Medical informational article explaining the causes, symptoms, diagnosis, and management options of PCOS based on expert insights from a fertility clinic.
Version:
1.5.0.0
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2025
Authors:
Gulisa Turashvili, MD, PhD; Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO; Giovanna A. Giannico, MD; Krisztina Hanley, MD; Anna Plotkin, MD; Anthony N. Karnezis, MD, PhD.
Note:
Accreditation Requirements
Date of Protocol Posting:
June 2024
Date of Required Use:
March 2025
Year:
2026
Region / City:
Australia
Document Type:
Informational Article
Organization / Institution:
The PCOS Clinic
Author:
Dr. Rebecca Harwin
Target Audience:
Women of reproductive age
Symptoms Covered:
Irregular menstruation, high testosterone, polycystic ovaries, acne, hirsutism, overweight/obesity, infertility, hair loss, skin changes, fatigue, mood disorders
Medical Focus:
Polycystic Ovary Syndrome (PCOS)
Diagnosis Criteria:
Menstrual irregularities, androgen levels, ultrasound findings, insulin resistance
Consultation Information:
PCOS Discovery Session via The PCOS Clinic
References:
www.ConquerYourPCOSNaturally.com
Note:
, www.ThePCOSClinic.com
Year:
2026
Databases:
PubMed, Embase, Cochrane Library, Web of Science
Topic:
Polycystic ovary syndrome, depression, anxiety
Document type:
Supplementary table
Author:
Not specified
Target population:
Patients with polycystic ovary syndrome and comorbid mental health conditions
Search period:
Up to 2026
Query type:
MeSH terms and title/abstract keywords
Number of results:
PubMed 7631, Embase 24191, Cochrane Library 2611, Web of Science 1114
Year:
2026
Institution:
S. Lal Singh Memorial College of Pharmacy (DBU)
Author:
Ruvaita Showakat
Document Type:
Review Article
Target Audience:
Medical students, healthcare professionals
Condition:
Polycystic Ovary Syndrome (PCOS)
Diagnostic Criteria:
Rotterdam criteria
Management Strategies:
Lifestyle modification, pharmacological therapy
Research Gaps:
Genetic and epigenetic factors, long-term treatment outcomes, population diversity
Future Directions:
Personalized medicine, digital health integration, holistic care
Year:
2021
Region:
Australia
Topic:
Pharmacology / Drug utilisation
Document type:
Report
Organization:
Drug Utilisation Sub-Committee (DUSC), Department of Health, Services Australia
Drug:
Tolvaptan
Condition:
Autosomal dominant polycystic kidney disease (ADPKD)
Population:
Adults with chronic kidney disease stage 1–3
Data source:
Pharmaceutical Benefits Scheme (PBS) database
Date of PBS listing:
1 January 2019
Treatment criteria:
Nephrologist management, eGFR 30–89 mL/min/1.73m², evidence of rapidly progressing disease
Monitoring requirements:
Liver function tests prior to initiation, monthly for 18 months, then every 3 months
Dosage forms:
15 mg, 30 mg, 45 mg, 60 mg, 90 mg tablets in split-dose regimens
Analysis period:
First and second year of PBS listing
Note:
Year
Topic:
Medical Necessity for Genetic Testing
Document Type:
Letter
Target Audience:
Medical Director
Year:
2026
Region / City:
Australia
Document Type:
Informational Article
Organization / Institution:
The PCOS Clinic
Author:
Dr. Rebecca Harwin
Target Audience:
Women of reproductive age
Symptoms Covered:
Irregular menstruation, high testosterone, polycystic ovaries, acne, hirsutism, overweight/obesity, infertility, hair loss, skin changes, fatigue, mood disorders
Medical Focus:
Polycystic Ovary Syndrome (PCOS)
Diagnosis Criteria:
Menstrual irregularities, androgen levels, ultrasound findings, insulin resistance
Consultation Information:
PCOS Discovery Session via The PCOS Clinic
References:
www.ConquerYourPCOSNaturally.com
Note:
, www.ThePCOSClinic.com
Year:
2026
Databases:
PubMed, Embase, Cochrane Library, Web of Science
Topic:
Polycystic ovary syndrome, depression, anxiety
Document type:
Supplementary table
Author:
Not specified
Target population:
Patients with polycystic ovary syndrome and comorbid mental health conditions
Search period:
Up to 2026
Query type:
MeSH terms and title/abstract keywords
Number of results:
PubMed 7631, Embase 24191, Cochrane Library 2611, Web of Science 1114
Year:
2026
Institution:
S. Lal Singh Memorial College of Pharmacy (DBU)
Author:
Ruvaita Showakat
Document Type:
Review Article
Target Audience:
Medical students, healthcare professionals
Condition:
Polycystic Ovary Syndrome (PCOS)
Diagnostic Criteria:
Rotterdam criteria
Management Strategies:
Lifestyle modification, pharmacological therapy
Research Gaps:
Genetic and epigenetic factors, long-term treatment outcomes, population diversity
Future Directions:
Personalized medicine, digital health integration, holistic care